These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27570126)

  • 1. Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics.
    Chang KM; Liu M
    Curr Opin Pharmacol; 2016 Oct; 30():93-105. PubMed ID: 27570126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
    Meng Z; Chen Y; Lu M
    Front Immunol; 2019; 10():3127. PubMed ID: 32117201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in therapeutics for chronic hepatitis B.
    Yang N; Bertoletti A
    Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
    Koh S; Bertoletti A
    Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon and Hepatitis B: Current and Future Perspectives.
    Ye J; Chen J
    Front Immunol; 2021; 12():733364. PubMed ID: 34557195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.
    Chen J; Yuan Z
    Virol Sin; 2014 Feb; 29(1):17-24. PubMed ID: 24452540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
    Gao Y; Zhang TY; Yuan Q; Xia NS
    Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathogenesis of Hepatitis B Virus.
    Tseng TC; Huang LR
    J Infect Dis; 2017 Nov; 216(suppl_8):S765-S770. PubMed ID: 29156047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?
    Bertoletti A; Gehring AJ
    PLoS Pathog; 2013; 9(12):e1003784. PubMed ID: 24367255
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward Curative Immunomodulation Strategies for Chronic Hepatitis B Virus Infection.
    Zhu W; Liu H; Zhang X
    ACS Infect Dis; 2019 May; 5(5):703-712. PubMed ID: 30907080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into immunotherapy for hepatitis B patients.
    Akbar SM; Al-Mahtab M; Jahan M; Yoshida O; Hiasa Y
    Expert Rev Gastroenterol Hepatol; 2016; 10(2):267-76. PubMed ID: 26626120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for Chronic Hepatitis B Virus Infection.
    Bertoletti A; Le Bert N
    Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.
    Bertoletti A; Ferrari C
    Gut; 2012 Dec; 61(12):1754-64. PubMed ID: 22157327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic interventions in chronic hepatitis B virus infection: a review.
    Wang L; Zou ZQ; Liu CX; Liu XZ
    J Immunol Methods; 2014 May; 407():1-8. PubMed ID: 24747918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
    Lobaina Y; Michel ML
    Vaccine; 2017 Apr; 35(18):2308-2314. PubMed ID: 28351734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of hepatitis B virus infection and potential for new therapies.
    Peppa D; Maini MK
    Br J Hosp Med (Lond); 2012 Oct; 73(10):581-4. PubMed ID: 23124289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection.
    Gehring AJ; Protzer U
    Gastroenterology; 2019 Jan; 156(2):325-337. PubMed ID: 30367834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathogenesis of chronic hepatitis B.
    Balmasova IP; Yushchuk ND; Mynbaev OA; Alla NR; Malova ES; Shi Z; Gao CL
    World J Gastroenterol; 2014 Oct; 20(39):14156-71. PubMed ID: 25339804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides.
    Akbar SM; Al-Mahtab M; Khan MS
    Expert Opin Biol Ther; 2013 Jul; 13(7):1063-74. PubMed ID: 23581572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
    Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
    J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.